The industrialised world is truly a marvel; through years of innovation and invention, society has been rewarded with extreme technological advances.

Immatics announced enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101.

London, UK, 22 August, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company developing transformative gene therapies…

Here in the EMJ offices, August would best be described by the team as a whirlwind, with not one, but six brand new publications ready for you to choose…

LUTEIN, a pigment found in kale, spinach, avocados, and eggs, may work to rejuvenate cognitive function, according to a study from the University of…

RESEARCH conducted at Kings College London, London, UK and Icahn School of Medicine, Mount Sinai, New York City, New York, USA has shown a link between…

United Kingdom, August 17, 2017: A warm welcome to the 2017 EMJ Reproductive Health eJournal! This instalment gives a complete review of…

Kisspeptin is a novel neuropeptide that came to prominence in the field of fertility in 2003, when it was discovered that genetic mutations causing…

Patients with polycystic ovary syndrome (PCOS) have unique endocrine and metabolic characteristics, whereby the incidence and potentiality of obesity, as…